Cancer Genetics Program

The Cancer Genetics Program is designed to increase knowledge in the area of hereditary cancer genetics. This slide-based, expert-led course provides a comprehensive collection on an array of topics related to the genetic cancer risk assessment process.  The course addresses ways to improve the taking and documenting of family history, as well as interpreting those results.  The program is composed of site-specific sections on core concepts that include recognition of hereditary cancer syndromes, quantitative risk assessment, establishing a cancer risk assessment service, and special counseling and ethical, legal, and social issues in cancer genetics.


Learning objectives:

  • Apply basic concepts of cancer genetics, risk assessment and currently available testing into patient care practices.
  • Recognize genetic testing for common cancer syndromes and how to interpret Variants of Unknown Significance (VUS)
  • Consider the emergent strategies and the latest advances in early detection cancers (breast, GI, etc.)
  • Analyze genome wide association studies (GWAS) and principles of next generation technology in tumor/germline DNA and gene panels.
  • Summarize key learnings from each core section and utilize approaches to improve the process of recognition and referral of hereditary cancer syndromes within physician practices.

This activity was made available on 5/28/2014 and will be reviewed on an annual basis to determine continued availability.  Participants can also earn a maximum of 10.0 AMA PRA Category 1 Credit(s)™  ACGME Competencies addressed: Medical Knowledge.  

IMPORTANT NOTE: The Cancer Genetics Program expires on April 20, 2019. Participants must complete all necessary course components by this date to be eligible to claim CME credit. 

Note: This course is accessible through mobile devices as well as personal computers